The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases…
The post The Evolution of Reverse Paym…


New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fourteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared …


Biotechblog